ClinicalTrials.Veeva

Menu
D

Duly Health and Care | 2614 W. Jefferson Street

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Estrogen
Trilaciclib
Lurbinectedin
Topotecan
Sacituzumab
Everolimus
Irinotecan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials
Status recently updated

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the phy...

Enrolling
Active, not recruiting
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Dexamethasone Mouth Rinse

Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate and compare the activity and safety of two experimental arms con...

Enrolling
Relapsed Small Cell Lung Cancer
Drug: Topotecan
Drug: Lurbinectedin

Trial sponsors

G
Genentech logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems